Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
Abstract
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are resistant to treatment early in the regimen.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2020
- Source ID
- 10.1039/d0sc02221g
Entities
People
- Anita Mahadevan-Jansen
- Bhuminder Singh
- Eugene C. Lin
- Galina Bogatcheva
- Giju Thomas
- Rizia Bardhan
- Xiaona Wen
- Yu-chuan Ou
Organizations
- Congressionally Directed Medical Research Programs
- Iowa State University
- National Chung Cheng University
- National Science Foundation
- United States Army
- Vanderbilt University
- Vanderbilt University Medical Center
- Vanderbilt-Ingram Cancer Center
- Yusuf Hamied Department of Chemistry